Veloxis Pharmaceuticals
18 clinical trials · Sponsor
◉ Watch Veloxis Pharmaceuticals
| Record | Firm | Date |
|---|---|---|
| VEL-101 to Prevent Rejection After Kidney Transplantation (NCT07290777) | Veloxis Pharmaceuticals | 2026-07-01 |
| A Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VEL-101 (NCT05238493) | Veloxis Pharmaceuticals | 2022-04-26 |
| Assess Safety and Tolerability of ART-123 + FOLFOX + Bevacizumab in Metastatic Colorectal Cancer Patients (NCT05251727) | Veloxis Pharmaceuticals | 2022-03-24 |
| A Trial Measuring ART-123 Ability to Prevent Sensory Neuropathy in Unresectable mCRC Subjects w/Oxaliplatin-based Chemo (NCT04492436) | Veloxis Pharmaceuticals | 2021-10-01 |
Track Veloxis Pharmaceuticals automatically
Every clearance here is in the API, with alerts when new ones post.